Archive

Archive for the ‘Positive clinical trials of its adult stem cell product’ Category

Mesoblast (ASX: MSB), Shares jumps on Positive stem cell Trials

June 9th, 2011 No comments

ASX: MSB’s shares have shot up after announcing positive clinical trials of its adult stem cell product involving patients with vascular disease. Read more…